an interdisciplinary approach to individualized imaging /
First Statement of Responsibility
[edited by] Mohsen Beheshti, Werner Langsteger, Alireza Rezaee ; associate editors, Markus Raderer, Niklaus Schaeffer.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Philadelphia, PA :
Name of Publisher, Distributor, etc.
Elsevier,
Date of Publication, Distribution, etc.
[2018]
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource :
Other Physical Details
illustrations
GENERAL NOTES
Text of Note
M-distant metastasis.
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
Front Cover; PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging; PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging; Copyright; Contributors; Preface; Contents; Abbreviations; 1 -- Head and Neck Cancers; BACKGROUND; General; Early Clinical Symptoms9; Standard Diagnostic Procedures10; Standard Treatment11-13; Prognostic Factors13-15; Five-Year Survival16; TUMOR CHARACTERISTICS AND TYPICAL BEHAVIOR; Histopathology2,17; N-lymph nodes2; M-distant metastasis2; TNM CLASSIFICATION13,19; Guidelines; EVIDENCE-BASED VIEWPOINTS; COST-EFFECTIVENESS.
Text of Note
Case 5: Staging Lung Cancer-Guiding Biopsy and RadiotherapyCase 6: Staging SCLC-Differentiation of Limited From Extended Stage; Case 7: NSCLC-Recurrence; Case 8: Mesothelioma-Treatment Monitoring; Case 9: Talc Pleurodesis; Case 10: Carcinoid Tumor-Very Low FDG-Avid Malignancies; REFERENCES; 3 -- Breast Cancer; BACKGROUND; General1,2; Early Clinical Symptoms1,3; Primary Diagnostic Procedures1,4; Standard Treatment5; Prognostic Factors6; Five-Year Survival7; TUMOR CHARACTERISTICS AND TYPICAL BEHAVIOR; Histopathology8; Distribution and Localization9-11; N-lymph nodes; T-primary.
Text of Note
CLINICAL POINT OF VIEWPITFALLS31-35; False Positive; False Negative; DISCUSSION; TEACHING CASES; Case 1: Staging, Laryngeal Cancer; Case 2: Staging, SCC, Base of the Tongue; Case 3: Staging, Sinus Piriform Cancer; Case 4: Cancer of Unknown Primary; Case 5: Staging, Adenoid Cystic Carcinoma; Case 6: Staging, Tonsillar Cancer With Incidental Second Cancer; Case 7: Staging, Oropharyngeal Cancer, Myelodysplastic Syndrome; Case 8: HNSCC, Recurrence; Case 9: Therapy Monitoring, Nasopharyngeal Cancer; Case 10: Staging and Restaging Rhabdomyosarcoma; REFERENCES; 2 -- Lung Cancer; BACKGROUND; General1.
Suspected Recurrence After Potentially Curative TherapyMetastatic Disease; Response to Therapy; PITFALLS57-59; False Positive; False Negative; DISCUSSION; Solitary Pulmonary Nodules; Staging Lung Cancer; Prognostic Value; Therapy Monitoring; Detection of Tumor Burden and Planning for Radiation Therapy; Comparison With Other Modalities; Radiopharmaceuticals Beyond FDG; CONCLUSION; TEACHING CASES; Case 1: Staging at SCLC; Case 2: Staging NSCLC-Early Detection of Distant Metastases; Case 3: Staging NSCLC-Atypical Distant Metastases; Case 4: Staging NSCLC-Atypical Distant Metastases.
0
8
8
8
8
SUMMARY OR ABSTRACT
Text of Note
Edited, authored, and reviewed by an expert team of oncologists and nuclear physicians/radiologists, this one-of-a-kind title helps you make the most of the critical role PET/CT plays in cancer staging and therapeutic responses to individualized treatments. Drs. Mohsen Beheshti, Werner Langsteger, and Alireza Rezaee place an emphasis on cutting-edge research and evidence-based practice, ensuring that you're up to date with every aspect of this fast-changing field. For each tumor entity, you'll find authoritative discussions of background, pathology, common pattern of spread, TNM classification, clinical guidelines, discussion, evidence-based recommendations, key points, and pitfalls.